On 8 April 2021, at Bhumisiri Mangalanusorn Building, King Chulalongkorn Memorial Hospital (KCMH), the Thai Red Cross Society (TRCS), in collaboration with Division of Rheumatology, the Department of Medicine, Faculty of Medicine, Chulalongkorn University, the Departments of Hematology, the Departments of Pulmonary and Critical Care Medicine, and the Departments of Infectious diseases, held a press conference to announce “Thailand’s first successful treatment of systemic sclerosis patients with pulmonary fibrosis by stem cell transplantation.”
Systemic sclerosis is an autoimmune disease that can cause malfunctions of many internal organs. It is characterized by the formation of fibrosis on the skin and internal organs. It hardens the skin and causes fibrosis in the lungs, and cardiac muscles, which can lead to an enlarged heart and heart failure. In patients with acute and aggressive progression, treatment by regenerating the immune system to regulate its function will help slow down the disease progression, reduce damage to the organs, and prevent premature death.
Reference Sources: some part of this news from https://www.chula.ac.th/en/news/46499/
